These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Leukapheresis in acute leukemia--is it necessary? Taft EG; Sullivan SA Prog Clin Biol Res; 1982; 88():189-205. PubMed ID: 7100210 [No Abstract] [Full Text] [Related]
9. [Successful prevention of cerebrovascular attack in chronic myelocytic leukemia with cytapheresis]. Imai J; Hayashi K; Nakanishi K; Murakami H; Hato T Rinsho Ketsueki; 1983 Jul; 24(7):944-6. PubMed ID: 6579321 [No Abstract] [Full Text] [Related]
10. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies. Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S Clin Transpl; 1996; ():281-90. PubMed ID: 9286578 [TBL] [Abstract][Full Text] [Related]
11. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Barrett AJ; Mavroudis D; Tisdale J; Molldrem J; Clave E; Dunbar C; Cottler-Fox M; Phang S; Carter C; Okunnieff P; Young NS; Read EJ Bone Marrow Transplant; 1998 Mar; 21(6):543-51. PubMed ID: 9543057 [TBL] [Abstract][Full Text] [Related]